Oryon Cell Therapies Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $32.7M

  • Investors
  • 3

Oryon Cell Therapies General Information

Description

Operator of a biopharmaceutical company intended to treat brain diseases. The company uses autologous cell therapy for the development of regenerative medicine to fundamentally restore normal motor function, enabling patients to recover from Parkinson's disease.

Contact Information

Website
www.oryoncelltherapies.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Boston, MA
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Life Sciences
Corporate Office
  • Boston, MA
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Oryon Cell Therapies Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC (Series A) 09-Mar-2026 $32.7M Completed Startup
To view Oryon Cell Therapies’s complete valuation and funding history, request access »

Oryon Cell Therapies Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Byers Capital Investment Advisory Family Office Minority
Neuro.Vc Corporation Minority
Takeda Ventures Corporate Venture Capital Minority
To view Oryon Cell Therapies’s complete investors history, request access »

Ready to get started?

Request a free trial

Oryon Cell Therapies FAQs

  • When was Oryon Cell Therapies founded?

    Oryon Cell Therapies was founded in 2020.

  • Where is Oryon Cell Therapies headquartered?

    Oryon Cell Therapies is headquartered in Boston, MA.

  • What industry is Oryon Cell Therapies in?

    Oryon Cell Therapies’s primary industry is Drug Discovery.

  • Is Oryon Cell Therapies a private or public company?

    Oryon Cell Therapies is a Private company.

  • What is Oryon Cell Therapies’s current revenue?

    The current revenue for Oryon Cell Therapies is .

  • How much funding has Oryon Cell Therapies raised over time?

    Oryon Cell Therapies has raised $32.7M.

  • Who are Oryon Cell Therapies’s investors?

    Byers Capital Investment Advisory, Neuro.Vc, and Takeda Ventures have invested in Oryon Cell Therapies.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process